BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study - Concepedia

Concepedia

Publication | Open Access

BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study

DOI Full Paper Access

50

Citations

36

References

2018

Year

John Munkhaugen, Vidar Ruddox, Sigrun Halvorsen, Toril Dammen, Morten Wang Fagerland, Kjersti Helene Hernæs, Nils Tore Vethe, Eva Prescott, Svend Eggert Jensen, Olaf Rødevand,

American Heart Journal

Abstract

The results from the BETAMI trial may have the potential of changing current clinical practice for treatment with β-blockers following MI in patients without reduced LVEF. EudraCT number 2018-000590-75.

References

	Year	Citations

Page 1